ENSG00000251605 and tuberculosis: GaMF1.39 potentiates the anti-TB activity of the NADH dehydrogenase (NDH) inhibitor clofazimine (CFZ), the cyt-bcc:aa3 inhibitor Telacebec (Q203) alone and in combination with the cyt-bd inhibitor ND-011992, as well as TBAJ-876, respectively.